z-logo
open-access-imgOpen Access
The Future of B-cell Activating Factor Antagonists in the Treatment of Systemic Lupus Erythematosus
Author(s) -
William Stohl
Publication year - 2017
Publication title -
journal of rheumatic diseases
Language(s) - English
Resource type - Journals
eISSN - 2093-940X
pISSN - 2233-4718
DOI - 10.4078/jrd.2017.24.2.65
Subject(s) - b cell activating factor , belimumab , medicine , clinical trial , immunology , systemic lupus erythematosus , b cell , oncology , antibody , disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom